Neuca SA (NEUP)

Currency in PLN
717.00
-2.00(-0.28%)
Delayed Data·
NEUP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
707.00730.00
52 wk Range
645.00857.00
Key Statistics
Bid/Ask
713.00 / 717.00
Prev. Close
719
Open
724
Day's Range
707-730
52 wk Range
645-857
Volume
536
Average Volume (3m)
1.8K
1-Year Change
3.913%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEUP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
924.64
Upside
+28.96%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Neuca SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 924.64
(+28.96% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
21/05/2026
EPS / Forecast
-- / --
Revenue / Forecast
3.56B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 38.31%
Dividend Yield
2.48%
Industry Median 1.16%
Annualised payout
17.80
Paid annually
5-Years Growth
+12.22%
Growth Streak

Compare NEUP to Peers and Sector

Metrics to compare
NEUP
Peers
Sector
Relationship
P/E Ratio
18.5x15.3x−0.5x
PEG Ratio
0.970.410.00
Price/Book
2.8x2.9x2.6x
Price / LTM Sales
0.2x1.1x3.0x
Upside (Analyst Target)
25.5%23.9%58.6%
Fair Value Upside
Unlock9.9%10.2%Unlock

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including prevention, diagnostics, treatment, and complementary services; and financing services, such as insurance, subscriptions, occupational medicine, preventive and medicine programmes, FFS, NFZ, public, private, and corporate payer services. In addition, the company offers TPA services, remote consultations, in person visits, diagnostic tests, and occupational medicine services; operates a medical helpline and medical facilities; and offers medicine through apteline.pl, an e-commerce medical ordering site. Further, it engages in running clinical trials in the field of outsourcing clinical research and conducting clinical research centres; provision of insurance products, including health insurance products. Additionally, the company provides advertising and marketing services to pharmaceutical market entities; and logistics services for pharmaceutical manufacturers. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.

Employees
5172
Market
Poland

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
655.48K14.55%471.29M
Other Institutional Investors
28.17K0.63%20.25M
Public Companies & Retail Investors
3.82M84.83%2.75B
Total
4.51M100.00%3.24B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.2.97%133,65996,101
Towarzystwo Funduszy Inwestycyjnych PZU SA2.95%132,82395,500

People Also Watch

6.675
COGP
-2.98%
13.3200
LBW
-2.06%
271.60
SNTP
-2.30%
24.50
APTP
-2.39%
194.60
CBF
-0.51%

FAQ

What Is the Neuca SA (Warsaw: NEUP) Share Price Today?

The Neuca SA stock price today is 717.00 PLN.

What Stock Exchange Does Neuca SA (NEUP) Trade On?

Neuca SA is listed and trades on the Warsaw Stock Exchange.

What Is the Ticker (Stock Symbol) for Neuca SA?

The stock symbol (also called a 'ticker') for Neuca SA is "NEUP."

Does Neuca SA Pay Dividends? What’s The Current NEUP Dividend Yield?

Yes, NEUP Pays Dividends to its Shareholders. The current Neuca SA dividend yield is 2.48%.

What Is the Current Neuca SA Market Capitalisation?

As of today, Neuca SA (Warsaw: NEUP) market cap is 3.20B PLN.

What Is Neuca SA's (NEUP) Earnings Per Share (TTM)?

The Neuca SA EPS is currently 38.31 (Trailing Twelve Months).

When Is the Next Neuca SA Earnings Date?

Neuca SA's next earnings report will be released on 27/08/2026.

Is NEUP a Buy or Sell From a Technical Analyst Perspective?

Based on today's Neuca SA moving averages and other technical indicators, the daily buy/sell signal for NEUP stock is Strong Sell.

How Many Times Has Neuca SA Stock Split?

Neuca SA has split 0 times. (See the NEUP stock split history page for full effective split date and price information.)

How Many Employees Does Neuca SA Have?

Neuca SA has 5172 employees, based on their latest Companies House report.

What is the current trading status of Neuca SA (Warsaw: NEUP)?

As of 08/06/2026, Neuca SA (NEUP) is trading at a share price of 717.00 PLN, with a previous close of 719.00 PLN. The stock has fluctuated within a day range of 707.00 PLN to 730.00 PLN, while its 52-week range spans from 645.00 PLN to 857.00 PLN.

What Is Neuca SA (NEUP) Price Target According to Analysts?

The average 12-month price target for Neuca SA is 924.64 PLN, with a high estimate of 1022 PLN and a low estimate of 830 PLN. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +28.96% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.